Ennishi, Daisuke
Healy, Shannon
Bashashati, Ali
Saberi, Saeed
Hother, Christoffer http://orcid.org/0000-0001-8778-9662
Mottok, Anja http://orcid.org/0000-0003-3125-0494
Chan, Fong Chun
Chong, Lauren
Abraham, Libin
Kridel, Robert http://orcid.org/0000-0003-0287-7124
Boyle, Merrill
Meissner, Barbara
Aoki, Tomohiro http://orcid.org/0000-0001-6782-8361
Takata, Katsuyoshi
Woolcock, Bruce W.
ViganĂ², Elena
Gold, Michael http://orcid.org/0000-0003-1222-3191
Molday, Laurie L.
Molday, Robert S. http://orcid.org/0000-0002-4479-1831
Telenius, Adele http://orcid.org/0000-0002-6901-5126
Li, Michael Y.
Wretham, Nicole http://orcid.org/0000-0001-8942-4560
Dos Santos, Nancy
Wong, Mark
Viller, Natasja N.
Uger, Robert A.
Duns, Gerben
Baticados, Abigail http://orcid.org/0000-0001-7990-8553
Madero, Angel
Bristow, Brianna N.
Farinha, Pedro http://orcid.org/0000-0001-9364-9391
Slack, Graham W.
Ben-Neriah, Susana
Lai, Daniel http://orcid.org/0000-0001-9203-6323
Zhang, Allen W. http://orcid.org/0000-0002-7606-089X
Salehi, Sohrab
Shulha, Hennady P.
Chiu, Derek S.
Mostafavi, Sara
Gerrie, Alina S.
Huang, Da Wei
Rushton, Christopher
Villa, Diego http://orcid.org/0000-0002-4625-3009
Sehn, Laurie H.
Savage, Kerry J.
Mungall, Andrew J. http://orcid.org/0000-0002-0905-2742
Weng, Andrew P.
Bally, Marcel B.
Morin, Ryan D. http://orcid.org/0000-0003-2932-7800
Cohen Freue, Gabriela V.
Staudt, Louis M.
Connors, Joseph M.
Marra, Marco A. http://orcid.org/0000-0001-7146-7175
Shah, Sohrab P.
Gascoyne, Randy D.
Scott, David W.
Steidl, Christian http://orcid.org/0000-0001-9842-9750
Funding for this research was provided by:
Terry Fox Research Institute (1023)
Article History
Received: 21 November 2019
Accepted: 7 January 2020
First Online: 24 February 2020
Competing interests
: D.W.S., J.M.C. and R.D.G. are inventors on a patent held by the National Cancer Institute that has been licensed by NanoString Technologies. C.S. has performed consultancy for Seattle Genetics, Curis Inc., Roche, AbbVie, Juno Therapeutics and Bayer, and has received research funding from Bristol-Myers Squibb and Trillium Therapeutics Inc. D.W.S. has performed consultancy for Janssen and Celgene and has received research funding from Roche/Genentech, Janssen and NanoString Technologies. R.D.G. has performed consultancy for Celgene. R.K. received travel support from Roche. D.V., A.S.G, K.J.S., J.M.C., L.H.S. and D.W.S. received institutional research funding from Roche. L.H.S. has performed consultancy and received honoraria from Amgen, Abbvie, Apobiologix, Celgene, Lundbeck, Janssen, Karyopharm, TG Therapeutics, Roche/Genentech, Teva and Takeda. K.J.S. received honoraria and provided consultancy to Bristol-Myers Squibb, Merck, Takeda, Verastem and Servier. A.S.G. received honoraria and provided consultancy to Janssen, AbbVie and Seattle Genetics. D.V. received honoraria from and participated in advisory boards for: Roche, Abbvie, Celgene, Seattle Genetics, Lundbeck, AstraZeneca, Nanostring, Janssen and Gilead.